Tuesday, November 24, 2009, 3:17AM AEST - The Australian Stockmarket opens in 6 hours and 43 minutes.
To create a watchlist or portfolio of shares, Register

Questcor Pharmaceuticals, Inc. (QCOR)

3:02AM AEST: 4.22 USD  Up 0.06 (1.44%)  
 MORE ON QCOR 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Questcor Pharmaceuticals, Inc. (NGM:QCOR) Delayed quote dataEdit
Last Trade:4.22 USD
Trade Time: 3:02AM AEST
Change:Up 0.06 (1.44%)
Prev Close:4.16
Open:4.15
Bid:4.21 x 600
Ask:4.23 x 2000
1y Target Est:8.75
Day's Range:4.15 - 4.31
52wk Range:3.10 - 9.81
Volume:178,187
Avg Vol (3m):628,733
Market Cap:270.77M
P/E (ttm):8.23
EPS (ttm):0.51
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add QCOR to Portfolio   Download Data

 HEADLINES 
Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc.
GlobeNewswire (Thu, Nov 19)
Playboy, Helicos: Early Volume Plays
at TheStreet.com (Wed, Nov 18)
QUESTCOR PHARMACEUTICALS INC Financials
EDGAR Online Financials (Sat, Nov 14)
QUESTCOR PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Nov 4)
HEADLINE STOCKS-U.S. small/midcap stocks to watch on Nov 3
at Reuters (Wed, Nov 4)
Questcor Pharmaceuticals Q3 2009 Earnings Call Transcript
at Seeking Alpha (Tue, Nov 3)
Questcor Pharmaceuticals, Inc. Earnings Call scheduled for 4:30 pm ET today
CCBN (Tue, Nov 3)
Questcor Announces Third Quarter 2009 Results
GlobeNewswire (Tue, Nov 3)
Q3 2009 Questcor Pharmaceuticals, Inc. Earnings Release - After Market Close
CCBN (Mon, Nov 2)
More Headlines for QCOR...

 ANALYST 
EPS Est (next year) (Dec-09) :0.37
EPS Est (in 2 years) (Dec-10) :0.43
Avg Rec (current)*:2.5
PEG Ratio:0.47
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Questcor Pharmaceuticals, Inc., a specialty pharmaceutical company, provides prescription drugs for central nervous system disorders. The company markets H.P.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices